GlassScriptPhysician profile
Amir D Tahernia
NPI 1902819477
$203,824.64
in general payments reported to CMS, 2019-2025
18 companies · $1,144 in 2025
The $1,144 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69K · 2020: $41K · 2021: $53K · 2022: $26K · 2023: $13K · 2024: $605 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $785 · Travel and Lodging: $621 · Royalty Or License: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,921.25 |
| Food and Beverage | $784.72 |
| Travel and Lodging | $620.59 |
| Royalty Or License | $311.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $163,902.99 | 2019-2023 | |
| Republic Spine | $14,583.34 | 2019 | |
| Arthrex, INC. | $9,539.89 | 2019 | |
| Seaspine Orthopedics Corporation | $7,422.02 | 2019-2022 | |
| Globus Medical, INC. | $5,317.63 | 2019-2025 | Excelsius Gps |
| Stryker Corporation | $908.19 | 2019-2025 | Mako, N/A |
| Hikma Pharmaceuticals USA | $421.25 | 2024 | Combogesic IV |
| Choice Spine, LLC | $333.37 | 2025 | Thunderbolt Minimally Invasive Pedicle Screw Systems, Veo Lateral Interbody Fusion System, Triton |
| Spineart USA INC | $320.70 | 2019-2021 | |
| Orthofix Medical, INC. | $311.78 | 2023-2024 | Hollywood |
| Abbott Laboratories | $178.37 | 2019 | |
| Cpm Medical Consultants, LLC | $150.01 | 2021 | |
| 4web, INC. | $139.24 | 2019 | |
| Si-Bone, INC. | $133.69 | 2021 | |
| Abbvie INC. | $123.82 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $38.35 | 2023 | Tapestry |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Tahernia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.